Leadership – Board of Directors – Row 2

Tom Schnettler
Board Member

Tom Schnettler

Board Member

Tom is vice chairman of Piper Sandler Companies, a managing director in the merchant banking group and co-CEO of PSC Capital Partners LLC, the registered investment adviser to the Piper Sandler merchant banking funds. Tom has held a number of leadership roles at Piper Sandler, including president and chief operating officer and chief financial officer. Earlier in his career, he cofounded and led the healthcare investment banking group.

Tom has served on the board of, or held board observation responsibility for, Akoya Biosciences, Torax Medical, Sapphire Digital, Sport Ngin, Xenex Disinfection Services and Elligo Health Research.

Tom graduated from Saint John’s University in Collegeville, Minnesota and holds a Juris doctorate from Harvard Law School.

Scott Mendel
Board Member

Scott Mendel

Board Member

Scott joined the Akoya Biosciences Board of Directors in June 2021, bringing over 25 years of experience in the diagnostics industry. He currently serves as CEO and President of GenMark Diagnostics, a highly innovative and successful molecular diagnostics company acquired by multinational healthcare company Roche. Scott joined GenMark as CFO in 2014 and was promoted to CEO in 2020. Prior to GenMark, he held senior-level leadership positions with The Active Network and GE Healthcare. Scott earned a B.S. in finance from Indiana University and an M.B.A. from Northwestern University’s Kellogg School of Management.

Myla Lai-Goldman, MD
Board Member

Myla Lai-Goldman, MD

Board Member

Myla joined the Akoya Biosciences Board of Directors in September 2021. A true pioneer and leader in the diagnostic industry, Dr. Lai-Goldman held various roles including Executive Vice President, Chief Medical Officer and Chief Scientific Officer at Laboratory Corporation of America Holdings (LabCorp) and its predecessor company, Roche Biomedical Laboratories, Inc from 1990 to 2008. Myla is currently the Chair of GeneCentric Therapeutics, a precision medicine company, which she co-founded and previously served as CEO and President. She is also a venture partner with Hatteras Venture Partners and managing partner of Personalized Science, LLC, a diagnostic consulting company that she founded in 2008. Board-certified in both anatomic and clinical pathology, she received her medical degree from Columbia University College of Physicians and Surgeons.

Brian McKelligon
Chief Executive Officer

Brian McKelligon

Chief Executive Officer

Brian joined Akoya Biosciences in July 2017 serving as the CEO, bringing his experience as a 25-year veteran of the life sciences market with a proven track record of building and commercializing products and services for both the research and clinical markets. Most recently, he drove corporate and business development at Cellular Dynamics International (acquired by FUJIFilm) with a focus on the development and partnering of their four cell therapy programs. Prior to that, Brian built and ran commercial organizations at 10X Genomics, Thermo Fisher Scientific / Life Technologies, Affymetrix (IPO, acquired by Thermo Fisher) and Ingenuity Systems (acquired by Qiagen). He came to Thermo Fisher and Life Technologies through their acquisition of Ion Torrent in 2010 where he was an early employee and built the global commercial organization.